Published in Anaerobe on April 16, 2011
A Study of the New Medical Device Polybactum® (POLARIS) | NCT02863536
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol (2013) 1.87
Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause (2015) 1.49
The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res (2012) 1.05
Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One (2014) 1.02
Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis (2014) 1.01
Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually active female adolescents. PLoS One (2012) 0.98
The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women. BMC Infect Dis (2015) 0.89
Purification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from Lactobacillus gasseri EV1461 isolated from the vagina of a healthy woman. BMC Microbiol (2016) 0.87
Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process. PLoS One (2013) 0.86
Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay. PLoS One (2012) 0.86
The human urinary microbiome and how it relates to urogynecology. Int Urogynecol J (2016) 0.84
Mucosal immunity in the female genital tract, HIV/AIDS. Biomed Res Int (2014) 0.81
Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation. Int J Environ Res Public Health (2014) 0.80
Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study. J Low Genit Tract Dis (2015) 0.79
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Sex Transm Dis (2015) 0.79
Sensitive Detection of Thirteen Bacterial Vaginosis-Associated Agents Using Multiplex Polymerase Chain Reaction. Biomed Res Int (2015) 0.78
Bacterial communities in neonatal feces are similar to mothers' placentae. Can J Infect Dis Med Microbiol (2015) 0.78
Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women. J Womens Health (Larchmt) (2015) 0.78
Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res (2016) 0.78
Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. Am J Transplant (2016) 0.77
Efficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis. ISRN Obstet Gynecol (2012) 0.76
Lower Genital Tract Infections in HIV-Infected Women: Can We Afford to Miss? J Obstet Gynaecol India (2014) 0.76
Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021. PLoS One (2017) 0.75
Preclinical Evaluation of Tolerability of a Selective, Bacteriostatic, Locally Active Vaginal Formulation. Curr Ther Res Clin Exp (2016) 0.75
Natural products as mediators of disease. Nat Prod Rep (2016) 0.75
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Microbial complexes in subgingival plaque. J Clin Periodontol (1998) 15.90
Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85
Vaginitis. N Engl J Med (1997) 5.30
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis (2007) 3.93
Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis (2008) 3.90
The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol (2008) 3.60
The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32
Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis (2003) 3.24
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis (2000) 2.64
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol (2006) 2.56
Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis (2001) 2.49
The effects of circumcision on the penis microbiome. PLoS One (2010) 2.15
Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 2.09
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol (2001) 1.95
Haemophilus vaginalis: vaginitis by inoculation from culture. Obstet Gynecol (1969) 1.87
Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis (1999) 1.84
Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy. J Infect Dis (1983) 1.77
Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol (2000) 1.74
A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol (2008) 1.63
Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS (2007) 1.61
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex Transm Dis (2005) 1.56
Social and sexual risk factors for bacterial vaginosis. Sex Transm Infect (2004) 1.54
Exposure to chronic stress and ethnic differences in rates of bacterial vaginosis among pregnant women. Am J Obstet Gynecol (2002) 1.43
Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis (2003) 1.38
Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc (2003) 1.30
Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol (2004) 1.24
Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol (2004) 1.20
Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr (2008) 1.16
Contraceptive use in women with bacterial vaginosis. Contraception (1997) 1.13
BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol (2003) 1.07
Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species. Infect Immun (2008) 1.05
The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol (1996) 0.99
Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis (2006) 0.98
Prevalence of Gardnerella vaginalis in male sexual partners of women with and without bacterial vaginosis. Sex Transm Dis (2009) 0.90